Ophthalmology · Port Orange, FL
NPI
1477759454
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
741 Dunlawton Ave
Port Orange, FL, 32127
Phone (800) 255-7188
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
83,972 services
Medicare patients, 2024
1,080
Average age 79
Drug cost, 2024
$1.9M
1,616 prescriptions
Company payments, 2025
$853
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farhad Safi was code J2777 (injection, faricimab-svoa, 0.1 mg), 65,984 times for 220 patients. In total Farhad Safi billed 83,972 services in 42 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 65,984 | 220 | $27.51 | $1.8M |
| 92202 Ophthalmological E&M | Office | 2,743 | 956 | $11.07 | $30K |
| 92134 Computerized Ophthalmic Imaging | Office | 2,706 | 976 | $28.15 | $76K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 2,640 | 36 | $86.62 | $229K |
| 92012 Ophthalmological E&M | Office | 2,479 | 779 | $61.79 | $153K |
| 67028 Intravitreal Injection | Office | 2,019 | 452 | $88.16 | $178K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,565 | 192 | $661.50 | $1.0M |
| J3490 Unclassified drugs | Office | 1,043 | 31 | $36.59 | $38K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 914 | 50 | $264.09 | $241K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 742 | 17 | $116.96 | $87K |
| 92014 Ophthalmological E&M | Office | 359 | 333 | $78.96 | $28K |
| 99204 Office E&M - New | Office | 213 | 213 | $120.09 | $26K |
| 92201 Ophthalmological E&M | Office | 182 | 169 | $15.56 | $2,833 |
| J7999 Compounded drug, not otherwise classified | Office | 58 | 24 | $59.63 | $3,459 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 44 | 38 | $0.76 | $33.57 |
By year: 2022 $1.4M for 7,491 services; 2023 $3.0M for 30,701 services; 2024 $4.0M for 83,972 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farhad Safi prescribed most often to Medicare patients was Ketorolac Tromethamine, with 350 prescriptions and refills. In total Farhad Safi wrote 1,616 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketorolac Tromethamine Generic | 350 | 442 | 149 | $15K |
| Eylea Aflibercept | 342 | 415 | 93 | $836K |
| Vabysmo Faricimab-Svoa | 277 | 283 | 56 | $794K |
| Prednisolone Acetate Generic | 212 | 263 | 135 | $9,794 |
| Moxifloxacin Moxifloxacin Hcl | 66 | 68 | 56 | $1,612 |
| Brimonidine Tartrate Generic | 49 | 65 | 23 | $2,149 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 49 | 107 | 29 | $906 |
| Timolol Maleate Generic | 38 | 68 | 16 | $296 |
| Izervay Avacincaptad Pegol Sodium/Pf | 25 | 47 | 12 | $69K |
| Atropine Sulfate Generic | 23 | 35 | 14 | $837 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 22 | 23 | 12 | $315 |
| Syfovre Pegcetacoplan/Pf | 21 | 31 | Under 11 | $81K |
| Latanoprost Generic | 19 | 43 | Under 11 | $113 |
| Bromfenac Sodium Generic | 17 | 29 | Under 11 | $2,885 |
| Diclofenac Sodium Generic | 16 | 16 | Under 11 | $222 |
Brand drugs: 1,078 claims; generic drugs: 538 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farhad Safi $853 ($853 in general payments such as food, travel and fees) from 10 companies. The largest payer was Genentech USA, Inc. with $377.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 10 | $377 |
| Alcon Vision LLC ALC | 1 | $138 |
| Apellis Pharmaceuticals, Inc. APLS | 5 | $115 |
| Sight Sciences, Inc. SGHT | 1 | $49.94 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $49.14 |
| Abbvie Inc. ABBV | 2 | $40.76 |
| Astellas Pharma US Inc 4503.T | 1 | $30.61 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $21.97 |
| Harrow Eye, LLC | 1 | $15.96 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $15.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.